PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Feb-2026 Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness Businesswire
06-Feb-2026 INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Businesswire
06-Feb-2026 Number of Shares and Voting Rights of ADOCIA as of January 31st, 2026 Businesswire
06-Feb-2026 HUBG BREAKING ALERT: Hub Group Inc. Hit with Securities Fraud Investigation after Financial Restatements Lead to Stock Drop -- Investors Notified to Contact BFA Law Businesswire
06-Feb-2026 Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC Businesswire
06-Feb-2026 Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026 Businesswire
06-Feb-2026 Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States Businesswire
06-Feb-2026 Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RARE Businesswire
06-Feb-2026 Harvest Healthcare Leaders Income ETF (HHL:TSX) Wins 2025 FundGrade A+ Award Businesswire
06-Feb-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Feb-2026 Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting Businesswire
06-Feb-2026 Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Businesswire
06-Feb-2026 RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm Businesswire
06-Feb-2026 GoodRx Powers Pricing for Leading Brand Medications on TrumpRx Businesswire
06-Feb-2026 Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans Businesswire
06-Feb-2026 BlinkRx Welcomes Former U.S. Senator Joe Manchin, Healthcare Executive Heather Manchin, as Senior Advisors Businesswire
06-Feb-2026 Aptar Reports Fourth Quarter and Annual 2025 Results Businesswire
06-Feb-2026 Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD) Businesswire
06-Feb-2026 Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq Businesswire
06-Feb-2026 Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire